Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €19.01 EUR
Change Today -0.395 / -2.04%
Volume 356.1K
CRBN On Other Exchanges
CRBN is not on other exchanges.
As of 11:35 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

corbion nv (CRBN) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/28/15 - €21.48
52 Week Low
10/16/14 - €10.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CORBION NV (CRBN)

Related News

No related news articles were found.

corbion nv (CRBN) Related Businessweek News

View More BusinessWeek News

corbion nv (CRBN) Details

Corbion N.V. develops, manufactures, and markets biobased products worldwide. It operates through Biobased Ingredients and Biobased Innovations business units. The company primarily provides lactic acid, lactic acid derivatives, and lactides; and functional blends containing enzymes, emulsifiers, minerals, and vitamins. It offers high performance biobased products made from renewable resources, such as sugar, starch, or other carbohydrates in various markets, including bakery, meat, pharmaceuticals and medical devices, home and personal care, packaging, automotive, coatings, and adhesives. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.

1,745 Employees
Last Reported Date: 04/9/15
Founded in 1919

corbion nv (CRBN) Top Compensated Officers

Chief Executive Officer and Member of Managem...
Total Annual Compensation: €663.0K
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €380.0K
Chief Technology Officer and Member of Manage...
Total Annual Compensation: €408.0K
Compensation as of Fiscal Year 2014.

corbion nv (CRBN) Key Developments

Corbion Reports Earnings Results for the First Quarter of 2015

Corbion reported earnings results for the first quarter of 2015. For the quarter, the company reported net sales were EUR 220 million against EUR 182.7 million a year ago. EBITA was EUR 37.2 million against EUR 25.1 million a year ago. Both net sales and EBITDA growth were strongly supported by currency effects.

Corbion N.V. Introduces PURALACT B3

Corbion N.V. introduced PURALACT B3. Corbion's PURALACT B3 is a new, commercially-available, performance building block for the coatings market. It is a unique, renewable, raw material for coating resins with very high purity that enhances resin efficiency and improves coating performance. By incorporating PURALACT B3 into solvent-based systems, the viscosity of resins can be reduced by up to 50% at comparable molecular weight. Formulation of high solid systems by adjusting the solvent content is possible, leading to simultaneous cost savings through reduced solvent use. For example, the amount of solvent required in alkyd resins for decorative coatings can be significantly decreased. The result is a system with a lower Volatile Organic Compound (VOC) content that enables a shift towards high solid formulations, with reduced costs in the final coating system. Additional resin efficiency parameters include an improved overall reaction yield and a significant reduction in reaction waste water.

Corbion N.V. Proposes Dividend on Common Shares and Additional Cash Dividend for the Year 2014; Reports Consolidated Earnings Results for the Fourth Quarter and Full Year of 2014

Corbion N.V. announced a proposal to distribute a 2014 regular dividend of EUR 0.21 per common share will be submitted for approval to the General Shareholders' Meeting to be held on 22 May 2015. In the same period, the company declared a dividend of EUR 0.15 per share. In addition to the regular dividend on common shares, EUR 50 million is proposed to be distributed as an additional cash dividend of EUR 0.81 per common share, at the same moment as the regular dividend. The proposed additional dividend on common shares will also be submitted for approval to the General Shareholders' Meeting to be held on 22 May 2015. The company reported consolidated earnings results for the fourth quarter and full year of 2014. For the quarter, the company reported Net Sales were increased by 8.7% to EUR 200.6 million, 2.9% organic growth. EBITDA excluding one-off costs was EUR 30.3 million, an organic increase of 26.0%. EBITDA was EUR 18.4 million against EUR 7.7 million a year ago. For the full year, net sales in Fiscal Year 2014 increased by 3.6% to EUR 770.1 million, 3.2% organic growth. EBITDA excluding one-off costs was EUR 109.6 million, an organic increase of 10.8%. EBITDA was EUR 94.8 million against EUR 7.7 million a year ago. ROCE was 12.6% against 12.3% a year ago. Capital expenditure on (in)tangible fixed assets was EUR 62.5 million against EUR 75.5 million a year ago. Loss after tax was EUR 18.3 million against profit after tax of EUR 5.2 million a year ago. Diluted loss per share was EUR 0.33 against EUR 0.03 a year ago. Cash flow from operating activities was EUR 66.8 million against EUR 34.1 million a year ago. Result before taxes from continuing operations was EUR 1.9 million against EUR 19.2 million a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRBN:NA €19.01 EUR -0.395

CRBN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Balchem Corp $58.11 USD -0.90
Chr Hansen Holding A/S kr329.10 DKK +1.80
Premier Foods PLC 45.00 GBp +2.00
Sensient Technologies Corp $67.79 USD -0.52
Tate & Lyle PLC 597.50 GBp +2.00
View Industry Companies

Industry Analysis


Industry Average

Valuation CRBN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CORBION NV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at